Acyclovir NDC 71205-578

NDC codes

FDA NDC Directory

Product NDC (as listed)71205-578Labeler and product segments. Claims need a package NDC.

Product NDC at billing width71205-0578Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
71205-578-30	71205057830	30 CAPSULE in 1 BOTTLE, PLASTIC (71205-578-30)Marketed from Jun 10, 2021
71205-578-60	71205057860	60 CAPSULE in 1 BOTTLE, PLASTIC (71205-578-60)Marketed from Jun 10, 2021
71205-578-90	71205057890	90 CAPSULE in 1 BOTTLE, PLASTIC (71205-578-90)Marketed from Jun 10, 2021

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Acyclovir
Generic name (nonproprietary): acyclovir
Active ingredients: Acyclovir — 200 mg/1
Dosage form: Capsule
Route: Oral
Labeler: Proficient Rx LP
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206261
Marketing start: Aug 17, 2017
Listing expires: Dec 31, 2026
Other FDA classes: DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
Identifiers: Product ID 71205-578_e95e1c62-32d4-46b8-ab0f-c662b837f9b8SPL ID e95e1c62-32d4-46b8-ab0f-c662b837f9b8SPL set ID e8056ec6-d2dc-48af-8550-82726af1c5c5RxCUI 197310UNII X4HES1O11FUPC 0371205578909
Pharmacologic class: Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205057830 followed by a unit qualifier and the quantity

Package 71205-0578-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 1, 2022.

Indications (excerpt from the label)

INDICATIONS AND USAGE Herpes Zoster Infections : Acyclovir is indicated for the acute treatment of herpes zoster (shingles). Genital Herpes : Acyclovir is indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. Chickenpox : Acyclovir is indicated for the treatment of chickenpox (varicella).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206261

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206261
Product	Strength	Form · route	Labeler	Product NDC
Acyclovir	Acyclovir 200 mg/1	CapsuleOral	Bryant Ranch Prepack	71335-1290
Acyclovir	Acyclovir 200 mg/1	CapsuleOral	Carlsbad Technology, Inc.	61442-114
Acyclovir	Acyclovir 200 mg/1	CapsuleOral	NuCare Pharmaceuticals,Inc.	68071-2299
Acyclovir	Acyclovir 200 mg/1	CapsuleOral	Golden State Medical Supply, Inc.	51407-852
Acyclovir	Acyclovir 200 mg/1	CapsuleOral	Bryant Ranch Prepack	63629-2009